Malaysia Atopic Dermatitis Therapeutics Market Analysis

Malaysia Atopic Dermatitis Therapeutics Market Analysis


$ 3999

The Malaysia Atopic Dermatitis Therapeutics Market was valued at US $20 Mn in 2022, and is predicted to grow at (CAGR) of 9% from 2023 to 2030, to US $39 Mn by 2030. The key drivers of this industry include increasing disease burden of Atopic Dermatitis (AD), supportive government policies, and technological advancements. The industry is primarily dominated by players such as Meda, Ivax, Pharmaniaga, Marufa, Sanofi, Novartis, Johnson & Johnson, and AbbVie among others.

ID: IN10MYPH435 CATEGORY: Pharmaceuticals GEOGRAPHY: Malaysia AUTHOR: Riddhi Solanki

Buy Now

Malaysia Atopic Dermatitis Therapeutics Market Analysis: Executive Summary

The Malaysia Atopic Dermatitis Therapeutics Market is at around US $20 Mn in 2022 and is projected to reach US $39 Mn in 2030, exhibiting a CAGR of 9% during the forecast period.

Atopic dermatitis (AD), commonly referred to as eczema, is a chronic inflammatory skin condition characterized by redness, itching, and inflammation. It often presents as localized patches on different areas of the body and can be aggravated by factors such as dry skin, stress, and exposure to specific irritants or allergens. Key symptoms include intense itching, redness, dryness, and the development of small, fluid-filled blisters that may release fluid and form crusts. Treatment typically involves a comprehensive approach, incorporating the use of emollients for skin moisturization, topical corticosteroids to alleviate inflammation, and, in severe cases, systemic immunosuppressants. Various pharmaceutical companies produce medications for atopic dermatitis, with noteworthy examples including Dupixent (Dupilumab) from Regeneron Pharmaceuticals and Sanofi, Eucrisa (Crisaborole) from Pfizer, and Elidel (Pimecrolimus) from Novartis.

The estimated overall prevalence of atopic dermatitis (AD) in Malaysia is approximately 13.4%. The market is being driven by significant factors, such as the increasing prevalence of AD supportive government policies and technological advancements in the therapeutics market. However, conditions such as poor reimbursement policies, a lack of human resources, and local competition limit the growth and potential of the market.

Malaysia Atopic Dermatitis Therapeutics Market Analysis 2022 to 2030

Market Dynamics

Market Growth Drivers

Increasing AD burden: The overall prevalence of AD is estimated to be around 13.4% in Malaysia. The burden of environmental factors such as pollution and dietary changes related to urbanization is connected to a higher prevalence of AD. Malaysia's diverse population, consisting of various ethnicities, has an increased genetic susceptibility to AD.

Supportive government policies: Initiatives such as Skim Sihat Selangor and Bantuan Sara Hidup, implemented by the government, aim to enhance healthcare accessibility and make medications more affordable, particularly for low-income families. The rise in private health insurance coverage offers financial protection for the costs associated with AD treatment.

Technological advancements: The introduction of specific biologic therapies, such as dupilumab, brings about substantial enhancements in the management of moderate to severe AD. Progress in genetic testing and the identification of biomarkers lays the foundation for personalized treatment strategies and better outcomes.

Market Restraints

Poor reimbursement policies: While the Malaysian healthcare system provides some public insurance coverage for specific treatments, it may not be all-encompassing. Insufficient reimbursement acts as a deterrent for patients to seek regular care, thus restricting market growth.

Lack of professionals: A scarcity of well-trained dermatologists and healthcare professionals proficient in handling atopic dermatitis can restrict the quality of care and adherence to treatment plans.

Local competition: The availability of diverse generic and branded topical steroids and emollients triggers price competition, constraining profit margins for pharmaceutical companies and hampering innovation in the development of new therapeutic options.

Healthcare Policies and Regulatory Landscape

Malaysia's healthcare regulatory landscape is governed by the Malaysian Ministry of Health (MOH) and its regulatory agency, the National Pharmaceutical Regulatory Agency (NPRA). The NPRA is responsible for ensuring the safety, efficacy, and quality of pharmaceuticals, cosmetics, and medicinal products in Malaysia.

Companies seeking to introduce new drugs to the Malaysian market must go through the NPRA's regulatory processes, which include rigorous evaluation and approval procedures to ensure compliance with local standards and regulations. The registration and licensing of pharmaceutical products involve the submission of comprehensive documentation, including data on product safety, efficacy, and quality, to the NPRA.

For new entrants in the Malaysian healthcare market, navigating the regulatory environment requires a thorough understanding of the country's regulatory requirements and standards. The NPRA plays a pivotal role in granting licenses for pharmaceutical products, and companies must adhere to the established procedures to obtain approval. The regulatory environment emphasizes the importance of compliance with safety and quality standards, making it essential for new entrants to invest in regulatory affairs and quality assurance.

Competitive Landscape

Key Players

  • Sanofi
  • GlaxoSmithKline
  • Pfizer
  • AbbVie
  • Novartis
  • Johnson & Johnson
  • Meda Pharmaceuticals
  • Marufa Sdn Bhd
  • Pharmaniaga Berhad
  • Ivax Pharmaceuticals

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Malaysia Atopic Dermatitis Therapeutics Market Segmentation

By Drug Class

  • Corticosteroids
  • Calcineurin Inhibitors
  • Immunosuppressants
  • Biologic Therapy
  • PDE-4 Inhibitor
  • Antibiotics
  • Antihistamines
  • Emollients

By Route of Administration

  • Topic
  • Oral
  • Injectable

By Severity type

  • Mild
  • Moderate
  • Severe

By Age Group

  • 18 years and below
  • 19 years and above

By Distribution channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Dermatology Clinics
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 08 March 2024
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up